Subscribe
shutterstock_-jejim1038406462-1
jejim / Shutterstock.com
10 September 2019AmericasSarah Morgan

Taiwanese biotech abandons drug R&D under Genentech MoU

Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Former Genentech employees charged with trade secrets theft
1 November 2018   Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Former Genentech employees charged with trade secrets theft
1 November 2018   Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

More on this story

Americas
Former Genentech employees charged with trade secrets theft
1 November 2018   Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug